Supernus Pharmaceuticals, Inc.
$SUPN
Public valuation for Supernus Pharmaceuticals, Inc. (SUPN). Fair value, signal, and key metrics — no sign-in required.
Current Price
$44.63
31% Undervalued
Fair Value Estimate
$58
🌱
Growth Stage
Fast-growing but still investing heavily in growth
Analyst Consensus
Target: $63.50
42% higher than current
Key Metrics
Market Cap
$2.6B
Forward P/E
20.2x
Operating Margin
-4.0%
Revenue Growth
22.4%
Get free watchlist alerts
Join the waitlist for valuation updates on $SUPN and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.